| US FDA approved drugs from 2015–June 2020: a perspective P Bhutani, G Joshi, N Raja, N Bachhav, PK Rajanna, H Bhutani, AT Paul, ... Journal of Medicinal Chemistry 64 (5), 2339-2381, 2021 | 392 | 2021 |
| Drugs targeting various stages of the SARS-CoV-2 life cycle: Exploring promising drugs for the treatment of Covid-19 R Poduri, G Joshi, G Jagadeesh Cellular signalling 74, 109721, 2020 | 161 | 2020 |
| Toward an understanding of structural insights of xanthine and aldehyde oxidases: an overview of their inhibitors and role in various diseases R Kumar, G Joshi, H Kler, S Kalra, M Kaur, R Arya Medicinal Research Reviews 38 (4), 1073-1125, 2018 | 97 | 2018 |
| Structural insights of cyclin dependent kinases: implications in design of selective inhibitors S Kalra, G Joshi, A Munshi, R Kumar European journal of medicinal chemistry 142, 424-458, 2017 | 79 | 2017 |
| Growth factors mediated cell signalling in prostate cancer progression: Implications in discovery of anti-prostate cancer agents G Joshi, PK Singh, A Negi, A Rana, S Singh, R Kumar Chemico-biological interactions 240, 120-133, 2015 | 70 | 2015 |
| A review on pharmacophoric designs of antiproliferative agents A Rana, JM Alex, M Chauhan, G Joshi, R Kumar Medicinal Chemistry Research 24, 903-920, 2015 | 65 | 2015 |
| Nano-Co-Delivery of Berberine and Anticancer Drug Using PLGA Nanoparticles: Exploration of Better Anticancer Activity and In Vivo Kinetics I Khan, G Joshi, KT Nakhate, Ajazuddin, R Kumar, U Gupta Pharmaceutical research 36, 1-17, 2019 | 59 | 2019 |
| Imine/amide–imidazole conjugates derived from 5-amino-4-cyano-N1-substituted benzyl imidazole: Microwave-assisted synthesis and anticancer activity via … A Negi, JM Alex, SM Amrutkar, AT Baviskar, G Joshi, S Singh, ... Bioorganic & medicinal chemistry 23 (17), 5654-5661, 2015 | 54 | 2015 |
| Pyrimidine-fused derivatives: Synthetic strategies and medicinal attributes G Joshi, H Nayyar, J Marin Alex, G S Vishwakarma, S Mittal, R Kumar Current Topics in Medicinal Chemistry 16 (28), 3175-3210, 2016 | 37 | 2016 |
| Relay tricyclic Pd (ii)/Ag (i) catalysis: design of a four-component reaction driven by nitrene-transfer on isocyanide yields inhibitors of EGFR DM Sawant, S Sharma, RS Pathare, G Joshi, S Kalra, S Sukanya, ... Chemical Communications 54 (82), 11530-11533, 2018 | 33 | 2018 |
| Dual inhibitors of epidermal growth factor receptor and topoisomerase IIα derived from a quinoline scaffold M Chauhan, G Joshi, H Kler, A Kashyap, SM Amrutkar, P Sharma, ... RSC advances 6 (81), 77717-77734, 2016 | 33 | 2016 |
| Pyrimidine containing epidermal growth factor receptor kinase inhibitors: Synthesis and biological evaluation G Joshi, H Nayyar, S Kalra, P Sharma, A Munshi, S Singh, R Kumar Chemical biology & drug design 90 (5), 995-1006, 2017 | 29 | 2017 |
| E-pharmacophore guided discovery of pyrazolo [1, 5-c] quinazolines as dual inhibitors of topoisomerase-I and histone deacetylase G Joshi, S Kalra, UP Yadav, P Sharma, PK Singh, S Amrutkar, AJ Ansari, ... Bioorganic Chemistry 94, 103409, 2020 | 28 | 2020 |
| Synthesis and biological evaluation of new 2, 5-dimethylthiophene/furan based N-acetyl pyrazolines as selective topoisomerase II inhibitors G Joshi, SM Amrutkar, AT Baviskar, H Kler, S Singh, UC Banerjee, ... RSC advances 6 (18), 14880-14892, 2016 | 27 | 2016 |
| Design, synthesis, biological evaluation of 3, 5-diaryl-4, 5-dihydro-1H-pyrazole carbaldehydes as non-purine xanthine oxidase inhibitors: Tracing the anticancer mechanism via … G Joshi, M Sharma, S Kalra, NS Gavande, S Singh, R Kumar Bioorganic Chemistry 107, 104620, 2021 | 25 | 2021 |
| Anticancer potential of some imidazole and fused imidazole derivatives: Exploring the mechanism via epidermal growth factor receptor (EGFR) inhibition S Kalra, G Joshi, M Kumar, S Arora, H Kaur, S Singh, A Munshi, R Kumar RSC Medicinal Chemistry 11 (8), 923-939, 2020 | 22 | 2020 |
| Design and Synthesis of Non-Covalent Imidazo[1,2-a]quinoxaline-Based Inhibitors of EGFR and Their Anti-Cancer Assessment M Kumar, G Joshi, S Arora, T Singh, S Biswas, N Sharma, ZR Bhat, ... Molecules 26 (5), 1490, 2021 | 21 | 2021 |
| Exploring the COVID-19 vaccine candidates against SARS-CoV-2 and its variants: where do we stand and where do we go? G Joshi, P Borah, S Thakur, P Sharma, Mayank, R Poduri Human Vaccines & Immunotherapeutics 17 (12), 4714-4740, 2021 | 19 | 2021 |
| Doxorubicin and Crocin Co-delivery by Polymeric Nanoparticles for Enhanced Anticancer Potential In Vitro and In Vivo I Khan, G Joshi, B Sarkar, KT Nakhate, Ajazuddin, AK Mantha, R Kumar, ... ACS Applied Bio Materials 3 (11), 7789-7799, 2020 | 19 | 2020 |
| Exploration of Pd-catalysed four-component tandem reaction for one-pot assembly of pyrazolo [1, 5-c] quinazolines as potential EGFR inhibitors AJ Ansari, G Joshi, UP Yadav, AK Maurya, VK Agnihotri, S Kalra, R Kumar, ... Bioorganic Chemistry 93, 103314, 2019 | 19 | 2019 |
Raj Kumar, FRSCProfessor of Medicinal/Pharmaceutical Chemistry, Central University of Punjab在 cup.edu.in 的电子邮件经过验证
